Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause Foetal growth restriction? 110 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Foetal growth restriction have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.2% of all adverse event reports for ARIPIPRAZOLE.

110
Reports of Foetal growth restriction with ARIPIPRAZOLE
0.2%
of all ARIPIPRAZOLE reports
2
Deaths
22
Hospitalizations

How Dangerous Is Foetal growth restriction From ARIPIPRAZOLE?

Of the 110 reports, 2 (1.8%) resulted in death, 22 (20.0%) required hospitalization, and 7 (6.4%) were considered life-threatening.

Is Foetal growth restriction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 110 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause Foetal growth restriction?

ASPIRIN (414) PREDNISOLONE (269) PREDNISONE (222) AZATHIOPRINE (200) ENOXAPARIN (198) TACROLIMUS (184) HYDROXYCHLOROQUINE (178) DEXAMETHASONE (172) METHYLDOPA (172) METHYLPREDNISOLONE (168)

Which ARIPIPRAZOLE Alternatives Have Lower Foetal growth restriction Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All Foetal growth restriction Reports All Drugs Causing Foetal growth restriction ARIPIPRAZOLE Demographics